OGN

Organon & Co (OGN)

About Organon & Co (OGN)

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Details

Daily high

$6.23

Daily low

$5.94

Price at open

$6.00

52 Week High

$15.36

52 Week Low

$5.76

Market cap

1.6B

Dividend yield

1.31%

Volume

3.9M

Avg. volume

3.7M

P/E ratio

8.50

Organon & Co News